Verification and Comparison of Chromogenic Factor VIII Activity Assays in Patients With Hemophilia Treated With and Without Emicizumab

참고문헌 (5)

1. Shima M, "Factor VIII-mimetic function of humanized bispecific antibody in hemophilia A", N Engl J Med, 374, pp.2044~2053 (2016)
2. Bowyer A, "Effects of emicizumab on APTT, one-stage and chromogenic assays of factor VIII in artificially spiked plasma and in samples from haemophilia A patients with inhibitors", Haemophilia, 26, pp.536~542 (2020)
3. Administration FaD, "HEMLIBRA (emicizumab-kxwh) injection for subcutaneous use, prescribing information" (2017), Initial U.S.
4. Jenkins PV, "Laboratory coagulation tests and emicizumab treatment A United Kingdom Haemophilia Centre Doctors’ Organisation guideline", Haemophilia, 26, pp.151~155 (2020)
5. Nougier C, "Emicizumab treatment : impact on coagulation tests and biological monitoring of haemostasis according to clinical situations(BIMHO group proposals)", Eur J Haematol, 105, pp.675~681 (2020)

관련 논문AI추천